We recently showed that the expression of soluble γc receptor (sγc) in T cells is highly upregulated upon TCR stimulation and inhibits the anti-tumor response of CD8+ T cells via regulating IL-2 and IL-15 signaling [185]. The gene discussed is IL2; the disease is neoplasm.